FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer August 8, 2016December 14, 2022 Alexandra Mulvey
CRI Scientist Receives Russian Federation National Award July 13, 2016December 14, 2022 Alexandra Mulvey
Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy July 6, 2016December 14, 2022 Alexandra Mulvey
Rational Combinations 360° Conference Will Feature Two of CRI’s Leading Scientists March 11, 2016December 14, 2022 Alexandra Mulvey
Oncogene Initiates Cancer Development through Immune Checkpoints March 10, 2016December 14, 2022 Alexandra Mulvey
Laurie H. Glimcher, MD, to Head Dana-Farber Cancer Institute February 23, 2016December 14, 2022 Alexandra Mulvey